Brazil’s Operation Car Wash originally focused on corruption at state-controlled oil company Petrobras. But recent developments indicate that other industries – including those in the medical device and pharmaceutical sectors – are now under scrutiny as well. In a guest article, Gary Giampetruzzi, a partner at Paul Hastings, and associates Jonathan Stevens and Thiago Ribeiro, provide an update on recent developments and advise medical device and other life-sciences manufacturers on how they can protect their interests in Brazil. See “Brazilian Enforcers Are MVPs in Odebrecht and Braskem Settlements” (Feb. 1, 2017).
-
- |
